Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.

Rosei, Enrico Agabiti

Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus. [electronic resource] - Journal of hypertension Feb 2005 - 435-44 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0263-6352

10.1097/00004872-200502000-00027 doi


Adult
Aged
Albuminuria--drug therapy
Angiotensin II Type 1 Receptor Blockers--pharmacology
Angiotensin-Converting Enzyme Inhibitors--pharmacology
Arteriosclerosis--drug therapy
Benzimidazoles--adverse effects
Biomarkers--blood
Biphenyl Compounds--adverse effects
Blood Pressure--drug effects
Diabetes Mellitus, Type 2--complications
Double-Blind Method
Enalapril--adverse effects
Female
Fibrinogen--analysis
Humans
Hypertension--drug therapy
Intercellular Adhesion Molecule-1--blood
Male
Middle Aged
Plasminogen Activator Inhibitor 1--blood
Tetrazoles--adverse effects
Vascular Cell Adhesion Molecule-1--blood
von Willebrand Factor--analysis